Megan Blewett

I am an investor at Scion Life Sciences & Iris Medicine Founder, focusing on creating and building. Harvard University graduate (2007-2011). Featured publications include 'Chemical proteomic map of dimethyl fumarate-sensitive cysteines in primary human T cells' in Science Signaling (Sep 2016) and 'A chemoproteomic platform to quantitatively map targets of lipid-derived electrophiles' in Nat Methods (Jan 2014).